Promedicon Conference 2027- Kyoto University, Japan

KYOTO, Japan - Sept. 13, 2026 - PRLog -- PROMEDICON 2027 (International Conference and Exhibition on Progressive Medicinal Chemistry) is a premier international conference that features breakthroughs in drug discovery, medicinal chemistry, artificial intelligence, and translational therapeutics. This top medicinal chemistry and drug discovery conference is organized by the Chemical Biology Society and the India Japan Society for Science, Education & Technology, the event brings together Nobel Laureates, leading researchers, pharmaceutical companies, biotechnology innovators, clinicians, students, ECR's and computational scientists from around the world. This highly rated medicinal chemistry and drug discovery conference will be held at the HORIBA Symposium Hall within Kyoto University's International Science Innovation Building in Kyoto, Japan, from April 12–14, 2027, during the famous Sakura (Cherry Blossom) season, offering an exceptional scientific and cultural experience.

PROMEDICON deliberately engineers networking at every level, going beyond traditional poster sessions to host "Pharma-Connect Roundtables" where attendees share tables with R&D heads from top twenty global pharmaceutical companies. A dedicated industry-academia lounge, daily "Collaboration Happy Hours," and a customized meeting-scheduler app ensure productive interactions with pharma and biotech professionals in a focused setting. This commitment to meaningful engagement ranks PROMEDICON among the top five and top ten medicinal chemistry and drug discovery conferences (https://medicinalchemistryconference.com/) based on speaker quality and attendance, consistently earning attendee ratings above 4.5 across all previous editions. The conference partners with leading scientific publishers to ensure all accepted full papers and selected extended abstracts appear in a special conference issue, with proceedings indexed in Web of Science and Scopus and published in high-impact journals with an impact factor exceeding 3.0, providing maximum visibility for career advancement. PROMEDICON also offers the most advanced drug discovery workshops among all upcoming medicinal chemistry conferences (https://medicinalchemistryconference.com/) with abstract deadlines in the next three months, featuring hands-on sessions on AI-driven de novo molecule generation, cryo-EM for structure-based design, automated high-throughput screening robotics, and real-world case studies in PROTAC optimization, along with symposia on RNA-targeting small molecules, degrader technologies, and covalent kinase inhibitors led by industry trainers from top biotech firms. The conference is consistently listed among the top ten medicinal chemistry conferences in Asia, with a research program featuring top-tier speakers including multiple Nobel Laureates, ACS Award winners, and R&D chiefs from major pharma, attended by professors from MIT, Cambridge, Oxford, Tokyo, Kyoto, and the National Institutes of Health. For career-focused attendees, PROMEDICON includes a dedicated career fair and mentoring sessions, making it one of the best medicinal chemistry and drug discovery conferences for pharmaceutical chemists and academic researchers (https://medicinalchemistryconference.com/) in 2027.

Conference Website: https://medicinalchemistryconference.com/